LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: LIAISON XS delivers a high technology solution for immunochemistry tests (Photo courtesy of DiaSorin)
Image: LIAISON XS delivers a high technology solution for immunochemistry tests (Photo courtesy of DiaSorin)

DiaSorin S.p.A. (‎Saluggia‎, Italy) is exhibiting its range of advanced diagnostic solutions at this year's WorldLab-EuroMedLab that are designed to help clinicians in the management of emergency patients.

At EuroMedLab Rome 2023, DiaSorin is presenting its industry-leading offering of fully-automated chemiluminescent immunoassay (CLIA) panels, designed specifically for diagnosing infectious diseases. The highlight of the event, however, is the LIAISON MeMed BV test - DiaSorin's groundbreaking solution for rapidly and accurately distinguishing between bacterial and viral infections. The LIAISON MeMed BV test is the first of its kind, a fully automated solution that uses data based on the host's response. This innovative test aids physicians in accurately distinguishing between bacterial and viral infections, thereby facilitating quicker, more informed decisions regarding treatment and patient management. Moreover, compared to conventional growth-based microbiology methods, this test enhances lab operational efficiency by saving time and reducing labor through its fully automated and high-throughput approach.

In addition, DiaSorin is highlighting the capabilities of its LIAISON XS analyzer - a high-tech solution for immunochemistry tests. The analyzer enables laboratories to boost both efficiency and clinical effectiveness for routine and specialty testing. Also on display at the event is the LIAISON XL, a fully automated chemiluminescence analyzer, designed to carry out complete sample processing (including sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.), measurement, and evaluation. The LIAISON XL, with its innovative features such as a fully automated solution, superior result quality, flexible configuration, and high efficiency, has the potential to significantly improve the productivity of immunoassay labs.

Related Links:
DiaSorin S.p.A.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.